

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.54839092 |
| 2 | postsynaptic membrane organization (GO:0001941) | 4.85780931 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.66462634 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.61465743 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.27359787 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.26762329 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.09430895 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.05659858 |
| 9 | vocalization behavior (GO:0071625) | 3.98873180 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.97842907 |
| 11 | base-excision repair, AP site formation (GO:0006285) | 3.84966955 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.82042560 |
| 13 | cellular response to interferon-beta (GO:0035458) | 3.79511345 |
| 14 | glutamate secretion (GO:0014047) | 3.78673349 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76913742 |
| 16 | protein localization to synapse (GO:0035418) | 3.74896441 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.72230583 |
| 18 | tRNA methylation (GO:0030488) | 3.70133515 |
| 19 | presynaptic membrane organization (GO:0097090) | 3.68951072 |
| 20 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.67286882 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.63478446 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.61055162 |
| 23 | synaptic vesicle maturation (GO:0016188) | 3.59922961 |
| 24 | DNA double-strand break processing (GO:0000729) | 3.59405617 |
| 25 | exploration behavior (GO:0035640) | 3.55289616 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 3.52586119 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.50367588 |
| 28 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.49445486 |
| 29 | DNA strand elongation (GO:0022616) | 3.48267047 |
| 30 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.45667566 |
| 31 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.44188687 |
| 32 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.36914601 |
| 33 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.34633624 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 3.34299054 |
| 35 | proteasome assembly (GO:0043248) | 3.33843993 |
| 36 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.32841144 |
| 37 | IMP biosynthetic process (GO:0006188) | 3.32599485 |
| 38 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30937633 |
| 39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.29450090 |
| 40 | regulation of chromatin binding (GO:0035561) | 3.28447745 |
| 41 | glutamate receptor signaling pathway (GO:0007215) | 3.27815164 |
| 42 | regulation of vesicle fusion (GO:0031338) | 3.22466295 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.21877466 |
| 44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.21874379 |
| 45 | amino sugar catabolic process (GO:0046348) | 3.21160815 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.21142397 |
| 47 | snRNA processing (GO:0016180) | 3.19366033 |
| 48 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.17615097 |
| 49 | protein localization to cilium (GO:0061512) | 3.17182446 |
| 50 | regulation of translation in response to stress (GO:0043555) | 3.15460551 |
| 51 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.14040188 |
| 52 | pentose metabolic process (GO:0019321) | 3.12726407 |
| 53 | snRNA metabolic process (GO:0016073) | 3.12381764 |
| 54 | neuronal action potential propagation (GO:0019227) | 3.11302876 |
| 55 | ribosome assembly (GO:0042255) | 3.10258882 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.09114602 |
| 57 | dosage compensation (GO:0007549) | 3.07335833 |
| 58 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05888358 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.01305404 |
| 60 | behavioral response to cocaine (GO:0048148) | 3.01140651 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 2.99960876 |
| 62 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.99659008 |
| 63 | mechanosensory behavior (GO:0007638) | 2.98644886 |
| 64 | long-term synaptic potentiation (GO:0060291) | 2.98625331 |
| 65 | nuclear pore complex assembly (GO:0051292) | 2.95729366 |
| 66 | nucleobase catabolic process (GO:0046113) | 2.95576095 |
| 67 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.95393403 |
| 68 | positive regulation of protein homooligomerization (GO:0032464) | 2.95331480 |
| 69 | catecholamine transport (GO:0051937) | 2.94787875 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94731030 |
| 71 | retinal rod cell development (GO:0046548) | 2.93903347 |
| 72 | mismatch repair (GO:0006298) | 2.92135082 |
| 73 | layer formation in cerebral cortex (GO:0021819) | 2.91208302 |
| 74 | respiratory burst (GO:0045730) | 2.90276260 |
| 75 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.89623894 |
| 76 | positive regulation of synapse assembly (GO:0051965) | 2.88634373 |
| 77 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.88381295 |
| 78 | mitochondrial RNA metabolic process (GO:0000959) | 2.87197739 |
| 79 | establishment of integrated proviral latency (GO:0075713) | 2.85870386 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.85514848 |
| 81 | sensory perception of smell (GO:0007608) | 2.84379700 |
| 82 | establishment of viral latency (GO:0019043) | 2.83848750 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83018857 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82662799 |
| 85 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.81809587 |
| 86 | mitotic nuclear envelope disassembly (GO:0007077) | 2.81503611 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 2.81454504 |
| 88 | neuron recognition (GO:0008038) | 2.79490227 |
| 89 | auditory behavior (GO:0031223) | 2.79347511 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.77087097 |
| 91 | synapse assembly (GO:0007416) | 2.76307617 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.75602963 |
| 93 | DNA replication initiation (GO:0006270) | 2.75562462 |
| 94 | axonal fasciculation (GO:0007413) | 2.75535383 |
| 95 | response to interferon-beta (GO:0035456) | 2.74927863 |
| 96 | nuclear envelope disassembly (GO:0051081) | 2.73615623 |
| 97 | membrane disassembly (GO:0030397) | 2.73615623 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72941667 |
| 99 | regulation of postsynaptic membrane potential (GO:0060078) | 2.72642049 |
| 100 | nuclear pore organization (GO:0006999) | 2.72572228 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.72215789 |
| 102 | RNA methylation (GO:0001510) | 2.71591103 |
| 103 | positive regulation of membrane potential (GO:0045838) | 2.70333446 |
| 104 | response to auditory stimulus (GO:0010996) | 2.69708308 |
| 105 | cardiolipin metabolic process (GO:0032048) | 2.68725613 |
| 106 | IMP metabolic process (GO:0046040) | 2.68498079 |
| 107 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68270916 |
| 108 | pyrimidine dimer repair (GO:0006290) | 2.67530495 |
| 109 | fear response (GO:0042596) | 2.67396489 |
| 110 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.66171821 |
| 111 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65943803 |
| 112 | positive regulation of synapse maturation (GO:0090129) | 2.65033530 |
| 113 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.63456670 |
| 114 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.62951287 |
| 115 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.61569874 |
| 116 | activation of protein kinase A activity (GO:0034199) | 2.61064816 |
| 117 | positive regulation of mitochondrial fission (GO:0090141) | 2.60677599 |
| 118 | lipopolysaccharide metabolic process (GO:0008653) | 2.60201164 |
| 119 | cell communication by electrical coupling (GO:0010644) | 2.59838241 |
| 120 | mitotic chromosome condensation (GO:0007076) | 2.59322325 |
| 121 | base-excision repair (GO:0006284) | 2.59267221 |
| 122 | N-acetylneuraminate metabolic process (GO:0006054) | 2.59147881 |
| 123 | neurotransmitter transport (GO:0006836) | 2.58682382 |
| 124 | positive regulation of synaptic transmission (GO:0050806) | 2.58477044 |
| 125 | synapse organization (GO:0050808) | 2.58197410 |
| 126 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.57743297 |
| 127 | positive regulation of neurotransmitter transport (GO:0051590) | 2.57464906 |
| 128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57404425 |
| 129 | behavioral response to ethanol (GO:0048149) | 2.57359028 |
| 130 | formation of translation preinitiation complex (GO:0001731) | 2.55502591 |
| 131 | positive regulation of vesicle fusion (GO:0031340) | 2.55443357 |
| 132 | tRNA modification (GO:0006400) | 2.54717041 |
| 133 | inner ear receptor cell development (GO:0060119) | 2.54356922 |
| 134 | pore complex assembly (GO:0046931) | 2.54116218 |
| 135 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.53628567 |
| 136 | membrane hyperpolarization (GO:0060081) | 2.52762630 |
| 137 | deoxyribonucleotide catabolic process (GO:0009264) | 2.51859739 |
| 138 | DNA unwinding involved in DNA replication (GO:0006268) | 2.50807877 |
| 139 | regulation of female receptivity (GO:0045924) | 2.50572675 |
| 140 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.50502404 |
| 141 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.50179525 |
| 142 | regulation of neurotransmitter secretion (GO:0046928) | 2.50153049 |
| 143 | regulation of synaptic plasticity (GO:0048167) | 2.49885280 |
| 144 | replication fork processing (GO:0031297) | 2.47810987 |
| 145 | respiratory system process (GO:0003016) | 2.47256586 |
| 146 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47070702 |
| 147 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.46908798 |
| 148 | cerebellar Purkinje cell layer development (GO:0021680) | 2.46782607 |
| 149 | immunoglobulin mediated immune response (GO:0016064) | 2.46607811 |
| 150 | deoxyribose phosphate catabolic process (GO:0046386) | 2.46525200 |
| 151 | retinal cone cell development (GO:0046549) | 2.46135663 |
| 152 | proline transport (GO:0015824) | 2.45704391 |
| 153 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.45628486 |
| 154 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.45361782 |
| 155 | cell differentiation in hindbrain (GO:0021533) | 2.45284992 |
| 156 | activation of adenylate cyclase activity (GO:0007190) | 2.45223073 |
| 157 | glial cell proliferation (GO:0014009) | 2.44555688 |
| 158 | negative regulation of hormone metabolic process (GO:0032351) | 2.43105794 |
| 159 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.43105794 |
| 160 | glucosamine-containing compound catabolic process (GO:1901072) | 2.42932991 |
| 161 | cellular potassium ion homeostasis (GO:0030007) | 2.42339368 |
| 162 | dendrite morphogenesis (GO:0048813) | 2.42192698 |
| 163 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.41929694 |
| 164 | neuromuscular process (GO:0050905) | 2.41652686 |
| 165 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.41457917 |
| 166 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.41414360 |
| 167 | regulation of beta-amyloid formation (GO:1902003) | 2.40512106 |
| 168 | DNA replication checkpoint (GO:0000076) | 2.38232126 |
| 169 | purine nucleobase biosynthetic process (GO:0009113) | 2.37521681 |
| 170 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.37479315 |
| 171 | purine nucleotide salvage (GO:0032261) | 2.37199471 |
| 172 | telomere maintenance via recombination (GO:0000722) | 2.37107965 |
| 173 | protein localization to chromosome, centromeric region (GO:0071459) | 2.36464884 |
| 174 | metallo-sulfur cluster assembly (GO:0031163) | 2.32989845 |
| 175 | iron-sulfur cluster assembly (GO:0016226) | 2.32989845 |
| 176 | modulation by virus of host process (GO:0019054) | 2.30191023 |
| 177 | DNA duplex unwinding (GO:0032508) | 2.29733275 |
| 178 | COPI coating of Golgi vesicle (GO:0048205) | 2.28936143 |
| 179 | Golgi transport vesicle coating (GO:0048200) | 2.28936143 |
| 180 | proline biosynthetic process (GO:0006561) | 2.27697543 |
| 181 | viral mRNA export from host cell nucleus (GO:0046784) | 2.26908774 |
| 182 | regulation of leukocyte degranulation (GO:0043300) | 2.26709917 |
| 183 | B cell mediated immunity (GO:0019724) | 2.26226789 |
| 184 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.25629366 |
| 185 | DNA geometric change (GO:0032392) | 2.25425291 |
| 186 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.25352229 |
| 187 | rRNA modification (GO:0000154) | 2.25251516 |
| 188 | spliceosomal snRNP assembly (GO:0000387) | 2.24199592 |
| 189 | negative regulation of circadian rhythm (GO:0042754) | 2.23609417 |
| 190 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.23439123 |
| 191 | DNA strand renaturation (GO:0000733) | 2.23256736 |
| 192 | tRNA aminoacylation for protein translation (GO:0006418) | 2.23240132 |
| 193 | positive regulation by symbiont of host defense response (GO:0052509) | 2.22792827 |
| 194 | modulation by symbiont of host defense response (GO:0052031) | 2.22792827 |
| 195 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.22792827 |
| 196 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.22792827 |
| 197 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.22792827 |
| 198 | modulation by symbiont of host immune response (GO:0052553) | 2.22792827 |
| 199 | mitotic recombination (GO:0006312) | 2.22718740 |
| 200 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.22698822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.22551882 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.58148912 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.52271699 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25348435 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21520936 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.20927326 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02141942 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.01927689 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.82941045 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.81038388 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.80295681 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77740566 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.77397911 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77061767 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77061767 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.72986307 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.69970406 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69461247 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.66521839 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.63819542 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62389665 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59556484 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59370078 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56968155 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.56638042 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49563708 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.41209156 |
| 28 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.38224284 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36932610 |
| 30 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.35242078 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33739214 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.32393916 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31812347 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29455981 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25283732 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.21887501 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.18467687 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16484958 |
| 39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.16442746 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13455278 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13109642 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02507825 |
| 43 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01958764 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01153545 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.99576561 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97572317 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96348062 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95306393 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94856744 |
| 50 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.94673050 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.94630627 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94242503 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92168348 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89440166 |
| 55 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89009293 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85019053 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.84073290 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83878716 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83723735 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83596885 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.82881832 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82264888 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.81789093 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78427749 |
| 65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78179132 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76832792 |
| 67 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75542272 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75146513 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74444462 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.73805146 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72808558 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.71201125 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70697964 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70680751 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68599995 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65406557 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65316359 |
| 78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65205925 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64610769 |
| 80 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64120859 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63458146 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63202314 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.62758400 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62539458 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61002614 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60894503 |
| 87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.60153246 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59779740 |
| 89 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58874538 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58056478 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58035424 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57371316 |
| 93 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56437605 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.56057545 |
| 95 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54849119 |
| 96 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.53135371 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.52496035 |
| 98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51677150 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50296220 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50051270 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49815024 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48415837 |
| 103 | MYC_22102868_ChIP-Seq_BL_Human | 1.47471828 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47166914 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46347615 |
| 106 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45352428 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45078516 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.44655303 |
| 109 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44072978 |
| 110 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44025660 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43012307 |
| 112 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41900870 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41036850 |
| 114 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39872003 |
| 115 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37494218 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37082961 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34955592 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34751429 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32132962 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31645091 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30213937 |
| 122 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29913311 |
| 123 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29725339 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29369246 |
| 125 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26982978 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26594662 |
| 127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24254007 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23747542 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22408302 |
| 130 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21150217 |
| 131 | MAF_26560356_Chip-Seq_TH1_Human | 1.20301450 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17421426 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15632113 |
| 134 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15065898 |
| 135 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14103212 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12882174 |
| 137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12734474 |
| 138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09843278 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09756591 |
| 140 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08943427 |
| 141 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.08473074 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08039473 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07804168 |
| 144 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07190075 |
| 145 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07176766 |
| 146 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06961706 |
| 147 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06551160 |
| 148 | MAF_26560356_Chip-Seq_TH2_Human | 1.06164943 |
| 149 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04787272 |
| 150 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04767754 |
| 151 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04324286 |
| 152 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02950870 |
| 153 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02820184 |
| 154 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01342113 |
| 155 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00483615 |
| 156 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00359625 |
| 157 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98914324 |
| 158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96472962 |
| 159 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96263412 |
| 160 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96218656 |
| 161 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95502892 |
| 162 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94499509 |
| 163 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93809309 |
| 164 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92847183 |
| 165 | MYB_26560356_Chip-Seq_TH1_Human | 0.92630926 |
| 166 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91590823 |
| 167 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90329794 |
| 168 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90273313 |
| 169 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88820543 |
| 170 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88620593 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87472703 |
| 172 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86805039 |
| 173 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86216798 |
| 174 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85995586 |
| 175 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85452306 |
| 176 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84360241 |
| 177 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84343731 |
| 178 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84277584 |
| 179 | AR_19668381_ChIP-Seq_PC3_Human | 0.83714201 |
| 180 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83610200 |
| 181 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82057063 |
| 182 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81714501 |
| 183 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81020111 |
| 184 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80923726 |
| 185 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80122874 |
| 186 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80031968 |
| 187 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78879105 |
| 188 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78714485 |
| 189 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78469956 |
| 190 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.77984466 |
| 191 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77075797 |
| 192 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76926942 |
| 193 | TCF4_23295773_ChIP-Seq_U87_Human | 0.75443301 |
| 194 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.75407830 |
| 195 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.74072848 |
| 196 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.73907030 |
| 197 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72672762 |
| 198 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.72635095 |
| 199 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72611210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.95132060 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.23639203 |
| 3 | MP0001984_abnormal_olfaction | 3.72511470 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 3.48756631 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.39555777 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.22754149 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.16446915 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.08557535 |
| 9 | MP0008057_abnormal_DNA_replication | 3.04219379 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.99380246 |
| 11 | MP0009278_abnormal_bone_marrow | 2.97473830 |
| 12 | MP0008058_abnormal_DNA_repair | 2.96551597 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.88648554 |
| 14 | MP0004270_analgesia | 2.82989292 |
| 15 | MP0003077_abnormal_cell_cycle | 2.66101086 |
| 16 | MP0009745_abnormal_behavioral_response | 2.65672374 |
| 17 | MP0009046_muscle_twitch | 2.56231527 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.48461892 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.45417285 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.43118861 |
| 21 | MP0002064_seizures | 2.40455467 |
| 22 | MP0003303_peritoneal_inflammation | 2.38558006 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.32753231 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.20005195 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.18997573 |
| 26 | MP0001486_abnormal_startle_reflex | 2.17261518 |
| 27 | MP0003329_amyloid_beta_deposits | 2.13916864 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 2.11104974 |
| 29 | MP0000372_irregular_coat_pigmentation | 2.09340986 |
| 30 | MP0002184_abnormal_innervation | 2.06901955 |
| 31 | MP0003879_abnormal_hair_cell | 2.04239391 |
| 32 | MP0002272_abnormal_nervous_system | 2.03678237 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 2.02818861 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 2.00822366 |
| 35 | MP0003718_maternal_effect | 1.94518407 |
| 36 | MP0003787_abnormal_imprinting | 1.91472875 |
| 37 | MP0000685_abnormal_immune_system | 1.90182586 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.86684304 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.86684304 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.84485722 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.84387597 |
| 42 | MP0008932_abnormal_embryonic_tissue | 1.82661144 |
| 43 | MP0005451_abnormal_body_composition | 1.81480193 |
| 44 | MP0009840_abnormal_foam_cell | 1.81333208 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.76065786 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.74667228 |
| 47 | MP0002419_abnormal_innate_immunity | 1.72953275 |
| 48 | MP0008260_abnormal_autophagy | 1.65991488 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.65855463 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.65465909 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.65297047 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.64144559 |
| 53 | MP0008569_lethality_at_weaning | 1.63326471 |
| 54 | MP0008995_early_reproductive_senescence | 1.61852491 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.61617801 |
| 56 | MP0005423_abnormal_somatic_nervous | 1.58654884 |
| 57 | MP0002090_abnormal_vision | 1.58463859 |
| 58 | MP0003436_decreased_susceptibility_to | 1.58264978 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.57503906 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.56998226 |
| 61 | MP0000778_abnormal_nervous_system | 1.55042997 |
| 62 | MP0001853_heart_inflammation | 1.54684513 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.53047838 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.52710932 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.51778652 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.51251215 |
| 67 | MP0001529_abnormal_vocalization | 1.49068150 |
| 68 | MP0002398_abnormal_bone_marrow | 1.47674805 |
| 69 | MP0005025_abnormal_response_to | 1.47134857 |
| 70 | MP0002723_abnormal_immune_serum | 1.45715161 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.45576566 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.45335376 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.44731249 |
| 74 | MP0002722_abnormal_immune_system | 1.44053454 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.43621200 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.43589230 |
| 77 | MP0003786_premature_aging | 1.42651888 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.42506386 |
| 79 | MP0001819_abnormal_immune_cell | 1.41475145 |
| 80 | MP0005646_abnormal_pituitary_gland | 1.41358647 |
| 81 | MP0001970_abnormal_pain_threshold | 1.39476885 |
| 82 | MP0001800_abnormal_humoral_immune | 1.36635627 |
| 83 | MP0000716_abnormal_immune_system | 1.36347330 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.32554740 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.32279346 |
| 86 | MP0010307_abnormal_tumor_latency | 1.31663843 |
| 87 | MP0000313_abnormal_cell_death | 1.31036620 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 1.30972576 |
| 89 | MP0002736_abnormal_nociception_after | 1.30717831 |
| 90 | MP0002752_abnormal_somatic_nervous | 1.29776843 |
| 91 | MP0000703_abnormal_thymus_morphology | 1.29239513 |
| 92 | MP0004924_abnormal_behavior | 1.28966058 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.28966058 |
| 94 | MP0002405_respiratory_system_inflammati | 1.28302434 |
| 95 | MP0006276_abnormal_autonomic_nervous | 1.27884527 |
| 96 | MP0002429_abnormal_blood_cell | 1.26223779 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 1.25633375 |
| 98 | MP0005499_abnormal_olfactory_system | 1.25406261 |
| 99 | MP0005394_taste/olfaction_phenotype | 1.25406261 |
| 100 | MP0005671_abnormal_response_to | 1.24942127 |
| 101 | MP0005623_abnormal_meninges_morphology | 1.24902930 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24680330 |
| 103 | MP0000358_abnormal_cell_content/ | 1.22718415 |
| 104 | MP0003172_abnormal_lysosome_physiology | 1.22513998 |
| 105 | MP0002735_abnormal_chemical_nociception | 1.21702621 |
| 106 | MP0002160_abnormal_reproductive_system | 1.20985653 |
| 107 | MP0002822_catalepsy | 1.18432525 |
| 108 | MP0000955_abnormal_spinal_cord | 1.18391441 |
| 109 | MP0005000_abnormal_immune_tolerance | 1.18002001 |
| 110 | MP0000350_abnormal_cell_proliferation | 1.17934555 |
| 111 | MP0005408_hypopigmentation | 1.16455437 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 1.16306633 |
| 113 | MP0004233_abnormal_muscle_weight | 1.16246069 |
| 114 | MP0003633_abnormal_nervous_system | 1.14473948 |
| 115 | MP0004858_abnormal_nervous_system | 1.14310152 |
| 116 | MP0003763_abnormal_thymus_physiology | 1.13334150 |
| 117 | MP0004130_abnormal_muscle_cell | 1.13215891 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 1.11988633 |
| 119 | MP0001963_abnormal_hearing_physiology | 1.11863866 |
| 120 | MP0002229_neurodegeneration | 1.11500325 |
| 121 | MP0001764_abnormal_homeostasis | 1.10830588 |
| 122 | MP0002009_preneoplasia | 1.09445283 |
| 123 | MP0002166_altered_tumor_susceptibility | 1.09431888 |
| 124 | MP0003121_genomic_imprinting | 1.06355537 |
| 125 | MP0000681_abnormal_thyroid_gland | 1.05568885 |
| 126 | MP0000604_amyloidosis | 1.03508712 |
| 127 | MP0008469_abnormal_protein_level | 1.01780804 |
| 128 | MP0001730_embryonic_growth_arrest | 1.01457852 |
| 129 | MP0005365_abnormal_bile_salt | 1.00845825 |
| 130 | MP0002152_abnormal_brain_morphology | 1.00081040 |
| 131 | MP0002102_abnormal_ear_morphology | 1.00005117 |
| 132 | MP0003868_abnormal_feces_composition | 0.99306606 |
| 133 | MP0004885_abnormal_endolymph | 0.99111574 |
| 134 | MP0005380_embryogenesis_phenotype | 0.98292423 |
| 135 | MP0001672_abnormal_embryogenesis/_devel | 0.98292423 |
| 136 | MP0001929_abnormal_gametogenesis | 0.98251614 |
| 137 | MP0004197_abnormal_fetal_growth/weight/ | 0.96928389 |
| 138 | MP0003690_abnormal_glial_cell | 0.96635436 |
| 139 | MP0001790_abnormal_immune_system | 0.95765106 |
| 140 | MP0005387_immune_system_phenotype | 0.95765106 |
| 141 | MP0005253_abnormal_eye_physiology | 0.95437149 |
| 142 | MP0003186_abnormal_redox_activity | 0.95435291 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95224555 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.94840602 |
| 145 | MP0004742_abnormal_vestibular_system | 0.94798777 |
| 146 | MP0005389_reproductive_system_phenotype | 0.93567812 |
| 147 | MP0002006_tumorigenesis | 0.92938768 |
| 148 | MP0001119_abnormal_female_reproductive | 0.92161009 |
| 149 | MP0001324_abnormal_eye_pigmentation | 0.91857160 |
| 150 | MP0000751_myopathy | 0.91813720 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.91770150 |
| 152 | MP0003634_abnormal_glial_cell | 0.91429168 |
| 153 | MP0004811_abnormal_neuron_physiology | 0.91070898 |
| 154 | MP0000026_abnormal_inner_ear | 0.90967757 |
| 155 | MP0001845_abnormal_inflammatory_respons | 0.90071917 |
| 156 | MP0000371_diluted_coat_color | 0.89876466 |
| 157 | MP0003984_embryonic_growth_retardation | 0.89532549 |
| 158 | MP0004808_abnormal_hematopoietic_stem | 0.89256011 |
| 159 | MP0003631_nervous_system_phenotype | 0.89251971 |
| 160 | MP0003122_maternal_imprinting | 0.89083015 |
| 161 | MP0004142_abnormal_muscle_tone | 0.87800638 |
| 162 | MP0002396_abnormal_hematopoietic_system | 0.86687144 |
| 163 | MP0006036_abnormal_mitochondrial_physio | 0.86489040 |
| 164 | MP0005195_abnormal_posterior_eye | 0.86193879 |
| 165 | MP0002249_abnormal_larynx_morphology | 0.85980452 |
| 166 | MP0005384_cellular_phenotype | 0.85312269 |
| 167 | MP0002080_prenatal_lethality | 0.83418552 |
| 168 | MP0001905_abnormal_dopamine_level | 0.83252586 |
| 169 | MP0002088_abnormal_embryonic_growth/wei | 0.82529545 |
| 170 | MP0001697_abnormal_embryo_size | 0.82381399 |
| 171 | MP0005535_abnormal_body_temperature | 0.82380331 |
| 172 | MP0003300_gastrointestinal_ulcer | 0.80802644 |
| 173 | MP0002876_abnormal_thyroid_physiology | 0.79193806 |
| 174 | MP0002210_abnormal_sex_determination | 0.78800653 |
| 175 | MP0001293_anophthalmia | 0.78721626 |
| 176 | MP0009697_abnormal_copulation | 0.78165232 |
| 177 | MP0008877_abnormal_DNA_methylation | 0.77710667 |
| 178 | MP0009785_altered_susceptibility_to | 0.77129981 |
| 179 | MP0003283_abnormal_digestive_organ | 0.76902260 |
| 180 | MP0001188_hyperpigmentation | 0.75731413 |
| 181 | MP0008874_decreased_physiological_sensi | 0.75497957 |
| 182 | MP0005187_abnormal_penis_morphology | 0.72076863 |
| 183 | MP0004085_abnormal_heartbeat | 0.71300098 |
| 184 | MP0002069_abnormal_eating/drinking_beha | 0.69704405 |
| 185 | MP0010678_abnormal_skin_adnexa | 0.69540506 |
| 186 | MP0000579_abnormal_nail_morphology | 0.68963847 |
| 187 | MP0003075_altered_response_to | 0.68788164 |
| 188 | MP0004215_abnormal_myocardial_fiber | 0.68412875 |
| 189 | MP0003123_paternal_imprinting | 0.67967172 |
| 190 | MP0003632_abnormal_nervous_system | 0.67782296 |
| 191 | MP0004145_abnormal_muscle_electrophysio | 0.67759719 |
| 192 | MP0004185_abnormal_adipocyte_glucose | 0.66312291 |
| 193 | MP0003953_abnormal_hormone_level | 0.64247659 |
| 194 | MP0000920_abnormal_myelination | 0.62520630 |
| 195 | MP0001944_abnormal_pancreas_morphology | 0.61040046 |
| 196 | MP0001727_abnormal_embryo_implantation | 0.60292394 |
| 197 | MP0010386_abnormal_urinary_bladder | 0.59427901 |
| 198 | MP0002078_abnormal_glucose_homeostasis | 0.57199653 |
| 199 | MP0003137_abnormal_impulse_conducting | 0.56715748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.77007193 |
| 2 | Visual hallucinations (HP:0002367) | 4.49671576 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.42171743 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.33727768 |
| 5 | Recurrent cutaneous fungal infections (HP:0011370) | 4.25791738 |
| 6 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.25791738 |
| 7 | Hyperventilation (HP:0002883) | 4.10796843 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.05104563 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88273338 |
| 10 | Atonic seizures (HP:0010819) | 3.75821551 |
| 11 | Upper motor neuron abnormality (HP:0002127) | 3.61381124 |
| 12 | Microvesicular hepatic steatosis (HP:0001414) | 3.55588603 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 3.55542364 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.52853375 |
| 15 | Febrile seizures (HP:0002373) | 3.52443813 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.51169625 |
| 17 | Hypothermia (HP:0002045) | 3.47069562 |
| 18 | Colitis (HP:0002583) | 3.41548146 |
| 19 | Focal seizures (HP:0007359) | 3.36187410 |
| 20 | Absence seizures (HP:0002121) | 3.11592605 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.04935298 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.02706408 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 2.97897526 |
| 24 | Myokymia (HP:0002411) | 2.97355294 |
| 25 | Retinal dysplasia (HP:0007973) | 2.93358963 |
| 26 | Squamous cell carcinoma (HP:0002860) | 2.92044834 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 2.87155038 |
| 28 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.83337805 |
| 29 | Recurrent fungal infections (HP:0002841) | 2.82558789 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.79001532 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.77218566 |
| 32 | Multiple enchondromatosis (HP:0005701) | 2.77058889 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.69193586 |
| 34 | Agitation (HP:0000713) | 2.67722322 |
| 35 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.67695427 |
| 36 | Abnormality of glycolysis (HP:0004366) | 2.67485596 |
| 37 | Thyroid-stimulating hormone excess (HP:0002925) | 2.66805706 |
| 38 | Viral hepatitis (HP:0006562) | 2.65512504 |
| 39 | Gait imbalance (HP:0002141) | 2.65296070 |
| 40 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65273673 |
| 41 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.65005394 |
| 42 | Dialeptic seizures (HP:0011146) | 2.61750208 |
| 43 | Clumsiness (HP:0002312) | 2.61298839 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60758708 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.58997603 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.57389179 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.57163021 |
| 48 | Hypoplastic pelvis (HP:0008839) | 2.54901317 |
| 49 | Narrow nasal bridge (HP:0000446) | 2.53698387 |
| 50 | Excessive salivation (HP:0003781) | 2.53379004 |
| 51 | Drooling (HP:0002307) | 2.53379004 |
| 52 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.52897621 |
| 53 | Villous atrophy (HP:0011473) | 2.52897621 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.52368786 |
| 55 | Anxiety (HP:0000739) | 2.50532122 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.50211701 |
| 57 | Recurrent skin infections (HP:0001581) | 2.49271448 |
| 58 | Cortical dysplasia (HP:0002539) | 2.48594107 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.47812955 |
| 60 | Broad-based gait (HP:0002136) | 2.47678385 |
| 61 | Ketoacidosis (HP:0001993) | 2.46475940 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46212731 |
| 63 | Hemiplegia (HP:0002301) | 2.44667255 |
| 64 | Hypercortisolism (HP:0001578) | 2.43742171 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.43380128 |
| 66 | Cutaneous melanoma (HP:0012056) | 2.42864200 |
| 67 | Depression (HP:0000716) | 2.42832426 |
| 68 | Meckel diverticulum (HP:0002245) | 2.42016984 |
| 69 | Rough bone trabeculation (HP:0100670) | 2.41574046 |
| 70 | Psychosis (HP:0000709) | 2.39448991 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.38927915 |
| 72 | Poor suck (HP:0002033) | 2.36289455 |
| 73 | Severe visual impairment (HP:0001141) | 2.35630230 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.35447435 |
| 75 | Progressive external ophthalmoplegia (HP:0000590) | 2.34574567 |
| 76 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.33517028 |
| 77 | Brushfield spots (HP:0001088) | 2.32881172 |
| 78 | Abnormality of the preputium (HP:0100587) | 2.32469477 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.30462930 |
| 80 | Decreased central vision (HP:0007663) | 2.29840676 |
| 81 | Oligomenorrhea (HP:0000876) | 2.29433910 |
| 82 | Bone marrow hypocellularity (HP:0005528) | 2.29190122 |
| 83 | Abnormality of the ileum (HP:0001549) | 2.27519942 |
| 84 | Truncal ataxia (HP:0002078) | 2.25540081 |
| 85 | Hemiparesis (HP:0001269) | 2.24893618 |
| 86 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24792357 |
| 87 | Keratoconus (HP:0000563) | 2.24287741 |
| 88 | Increased corneal curvature (HP:0100692) | 2.24287741 |
| 89 | Poor eye contact (HP:0000817) | 2.23535409 |
| 90 | Medulloblastoma (HP:0002885) | 2.22632429 |
| 91 | Congenital primary aphakia (HP:0007707) | 2.21655578 |
| 92 | Abnormality of T cells (HP:0002843) | 2.19474291 |
| 93 | Meningitis (HP:0001287) | 2.18425334 |
| 94 | Impaired social interactions (HP:0000735) | 2.18415353 |
| 95 | Abnormal social behavior (HP:0012433) | 2.18415353 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.17712959 |
| 97 | Ankle clonus (HP:0011448) | 2.17610733 |
| 98 | Inflammation of the large intestine (HP:0002037) | 2.16747348 |
| 99 | Hand muscle atrophy (HP:0009130) | 2.16630734 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 2.15302960 |
| 101 | Exotropia (HP:0000577) | 2.15143952 |
| 102 | Generalized myoclonic seizures (HP:0002123) | 2.14884754 |
| 103 | Granulocytopenia (HP:0001913) | 2.13927532 |
| 104 | Respiratory difficulties (HP:0002880) | 2.11202788 |
| 105 | Abnormality of the lower motor neuron (HP:0002366) | 2.11061632 |
| 106 | Abnormality of chromosome stability (HP:0003220) | 2.09524038 |
| 107 | Polyphagia (HP:0002591) | 2.09334064 |
| 108 | Restlessness (HP:0000711) | 2.08855243 |
| 109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07991827 |
| 110 | Recurrent viral infections (HP:0004429) | 2.07068839 |
| 111 | Blue irides (HP:0000635) | 2.06142980 |
| 112 | Leukopenia (HP:0001882) | 2.05538687 |
| 113 | Cellular immunodeficiency (HP:0005374) | 2.05479838 |
| 114 | Abnormal eating behavior (HP:0100738) | 2.05303238 |
| 115 | Abnormality of the parathyroid morphology (HP:0011766) | 2.04447557 |
| 116 | Ketosis (HP:0001946) | 2.02868379 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01194070 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01194070 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01194070 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 1.99527556 |
| 121 | Cortical visual impairment (HP:0100704) | 1.98131884 |
| 122 | Chromsome breakage (HP:0040012) | 1.97004625 |
| 123 | Encephalitis (HP:0002383) | 1.95699177 |
| 124 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.95652664 |
| 125 | Combined immunodeficiency (HP:0005387) | 1.92584329 |
| 126 | Obstructive lung disease (HP:0006536) | 1.90919614 |
| 127 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90919614 |
| 128 | Tinnitus (HP:0000360) | 1.90236018 |
| 129 | Megalencephaly (HP:0001355) | 1.90194440 |
| 130 | Severe global developmental delay (HP:0011344) | 1.90095327 |
| 131 | Small intestinal stenosis (HP:0012848) | 1.89111778 |
| 132 | Duodenal stenosis (HP:0100867) | 1.89111778 |
| 133 | Lymphoma (HP:0002665) | 1.88509256 |
| 134 | Horseshoe kidney (HP:0000085) | 1.88424005 |
| 135 | Hypoplasia of the iris (HP:0007676) | 1.88356900 |
| 136 | Colon cancer (HP:0003003) | 1.87821528 |
| 137 | Optic nerve coloboma (HP:0000588) | 1.87617230 |
| 138 | Status epilepticus (HP:0002133) | 1.87586824 |
| 139 | Hypertensive crisis (HP:0100735) | 1.87554880 |
| 140 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.87552433 |
| 141 | Postural instability (HP:0002172) | 1.86408908 |
| 142 | Stereotypic behavior (HP:0000733) | 1.86253947 |
| 143 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85790934 |
| 144 | Abnormal trabecular bone morphology (HP:0100671) | 1.85317054 |
| 145 | Medial flaring of the eyebrow (HP:0010747) | 1.84712065 |
| 146 | Cutaneous photosensitivity (HP:0000992) | 1.84664109 |
| 147 | Hepatoblastoma (HP:0002884) | 1.84274371 |
| 148 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83622326 |
| 149 | Abnormality of alanine metabolism (HP:0010916) | 1.83622326 |
| 150 | Hyperalaninemia (HP:0003348) | 1.83622326 |
| 151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83383859 |
| 152 | Impaired smooth pursuit (HP:0007772) | 1.83077961 |
| 153 | Loss of speech (HP:0002371) | 1.82443467 |
| 154 | Premature graying of hair (HP:0002216) | 1.82249439 |
| 155 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82034933 |
| 156 | Severe Myopia (HP:0011003) | 1.81250683 |
| 157 | Abnormality of lateral ventricle (HP:0030047) | 1.80673570 |
| 158 | Genital tract atresia (HP:0001827) | 1.80424967 |
| 159 | Inability to walk (HP:0002540) | 1.80303622 |
| 160 | Dysdiadochokinesis (HP:0002075) | 1.79735473 |
| 161 | Hydroureter (HP:0000072) | 1.79688311 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.79458696 |
| 163 | Cholecystitis (HP:0001082) | 1.79458696 |
| 164 | Trismus (HP:0000211) | 1.78836491 |
| 165 | Abnormality of the carotid arteries (HP:0005344) | 1.78136535 |
| 166 | Akinesia (HP:0002304) | 1.78004246 |
| 167 | Morphological abnormality of the middle ear (HP:0008609) | 1.77689100 |
| 168 | Postural tremor (HP:0002174) | 1.77391316 |
| 169 | Neutropenia (HP:0001875) | 1.77229143 |
| 170 | Fatigue (HP:0012378) | 1.77119610 |
| 171 | Basal cell carcinoma (HP:0002671) | 1.76648520 |
| 172 | Abnormal sex determination (HP:0012244) | 1.76587097 |
| 173 | Sex reversal (HP:0012245) | 1.76587097 |
| 174 | Hyperglycinemia (HP:0002154) | 1.75293116 |
| 175 | Progressive neurologic deterioration (HP:0002344) | 1.75187761 |
| 176 | Abnormality of macular pigmentation (HP:0008002) | 1.74951141 |
| 177 | Severe combined immunodeficiency (HP:0004430) | 1.74875411 |
| 178 | Cleft eyelid (HP:0000625) | 1.74285197 |
| 179 | Delayed myelination (HP:0012448) | 1.74191042 |
| 180 | Hypoventilation (HP:0002791) | 1.73902967 |
| 181 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73281317 |
| 182 | Partial agenesis of the corpus callosum (HP:0001338) | 1.73237853 |
| 183 | Premature ovarian failure (HP:0008209) | 1.72902620 |
| 184 | IgM deficiency (HP:0002850) | 1.72858367 |
| 185 | Scanning speech (HP:0002168) | 1.72410021 |
| 186 | True hermaphroditism (HP:0010459) | 1.71674451 |
| 187 | Generalized hypopigmentation of hair (HP:0011358) | 1.71359942 |
| 188 | Tracheoesophageal fistula (HP:0002575) | 1.70855267 |
| 189 | Mutism (HP:0002300) | 1.70744169 |
| 190 | Specific learning disability (HP:0001328) | 1.70524848 |
| 191 | Absent speech (HP:0001344) | 1.70165667 |
| 192 | Progressive hearing impairment (HP:0001730) | 1.69091737 |
| 193 | Lower limb hyperreflexia (HP:0002395) | 1.68163232 |
| 194 | Agnosia (HP:0010524) | 1.67365293 |
| 195 | Poikiloderma (HP:0001029) | 1.65855925 |
| 196 | Acute hepatic failure (HP:0006554) | 1.64463392 |
| 197 | Horizontal nystagmus (HP:0000666) | 1.64199631 |
| 198 | Increased serum ferritin (HP:0003281) | 1.62195000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 6.76611734 |
| 2 | SRPK1 | 4.12126314 |
| 3 | STK16 | 3.99411342 |
| 4 | CASK | 3.45105463 |
| 5 | CDK19 | 3.13214577 |
| 6 | IRAK4 | 3.13080831 |
| 7 | PHKG1 | 3.06953347 |
| 8 | PHKG2 | 3.06953347 |
| 9 | NTRK3 | 3.02861342 |
| 10 | EPHA4 | 3.02239606 |
| 11 | MARK1 | 2.75377426 |
| 12 | EPHB1 | 2.72489005 |
| 13 | MAP3K9 | 2.68761765 |
| 14 | TRIM28 | 2.65783895 |
| 15 | SIK3 | 2.46960525 |
| 16 | TNIK | 2.37826590 |
| 17 | DAPK2 | 2.30000005 |
| 18 | ZAK | 2.08731679 |
| 19 | ACVR1B | 2.04767585 |
| 20 | MAP4K1 | 2.02865860 |
| 21 | BCR | 2.02394950 |
| 22 | MAP3K12 | 1.92959575 |
| 23 | BMPR1B | 1.88901512 |
| 24 | RPS6KA4 | 1.86905052 |
| 25 | MAP2K7 | 1.79682150 |
| 26 | CDC7 | 1.73489785 |
| 27 | MAP2K3 | 1.70230100 |
| 28 | NTRK2 | 1.66231097 |
| 29 | TGFBR1 | 1.62283923 |
| 30 | GRK7 | 1.57892021 |
| 31 | EIF2AK1 | 1.51860726 |
| 32 | CAMKK2 | 1.49064652 |
| 33 | MAP3K4 | 1.45580236 |
| 34 | NTRK1 | 1.45297502 |
| 35 | RIPK4 | 1.44425920 |
| 36 | SIK2 | 1.44210158 |
| 37 | DAPK1 | 1.43264334 |
| 38 | MAPK13 | 1.41941142 |
| 39 | PAK6 | 1.39072230 |
| 40 | GRK6 | 1.38164376 |
| 41 | BRD4 | 1.37543864 |
| 42 | TXK | 1.33329715 |
| 43 | MAP3K13 | 1.32203327 |
| 44 | GRK5 | 1.30905681 |
| 45 | EIF2AK3 | 1.29218246 |
| 46 | LMTK2 | 1.27504541 |
| 47 | FGFR4 | 1.25528690 |
| 48 | PDK3 | 1.25288951 |
| 49 | PDK4 | 1.25288951 |
| 50 | INSRR | 1.24262302 |
| 51 | MINK1 | 1.23842126 |
| 52 | MAP3K3 | 1.23667152 |
| 53 | CDK8 | 1.22341706 |
| 54 | MAPK15 | 1.21791929 |
| 55 | NME2 | 1.17405606 |
| 56 | EPHA3 | 1.16520069 |
| 57 | NUAK1 | 1.15506844 |
| 58 | MUSK | 1.12782470 |
| 59 | FES | 1.12395763 |
| 60 | OXSR1 | 1.11085245 |
| 61 | ATR | 1.07858971 |
| 62 | SCYL2 | 1.05630879 |
| 63 | PIM2 | 1.02244377 |
| 64 | RAF1 | 0.99722260 |
| 65 | CDK5 | 0.98935302 |
| 66 | CAMKK1 | 0.98295073 |
| 67 | CDK7 | 0.97039581 |
| 68 | TSSK6 | 0.96379647 |
| 69 | BLK | 0.95460627 |
| 70 | FGFR3 | 0.95341013 |
| 71 | FLT3 | 0.95224813 |
| 72 | CAMK2A | 0.94572793 |
| 73 | HIPK2 | 0.93022849 |
| 74 | RIPK1 | 0.92407107 |
| 75 | RPS6KA5 | 0.91994506 |
| 76 | ARAF | 0.91743979 |
| 77 | MAP2K4 | 0.91534021 |
| 78 | PLK4 | 0.90856697 |
| 79 | CSNK1A1L | 0.89628220 |
| 80 | TGFBR2 | 0.87478983 |
| 81 | CAMK2B | 0.87289399 |
| 82 | AURKA | 0.85843140 |
| 83 | CSNK1G2 | 0.82731086 |
| 84 | CAMK2D | 0.77783284 |
| 85 | TTK | 0.77075768 |
| 86 | IRAK1 | 0.76523139 |
| 87 | CSK | 0.76029376 |
| 88 | PIM1 | 0.75470693 |
| 89 | PLK1 | 0.75284232 |
| 90 | DYRK2 | 0.74196863 |
| 91 | TBK1 | 0.73103200 |
| 92 | ALK | 0.72582503 |
| 93 | JAK2 | 0.72273995 |
| 94 | MAP3K11 | 0.71370376 |
| 95 | LATS2 | 0.71081742 |
| 96 | EEF2K | 0.68225219 |
| 97 | KSR1 | 0.66931452 |
| 98 | SGK494 | 0.66397037 |
| 99 | SGK223 | 0.66397037 |
| 100 | IKBKE | 0.66162066 |
| 101 | KSR2 | 0.66129735 |
| 102 | MOS | 0.65875413 |
| 103 | EPHB2 | 0.65468514 |
| 104 | DYRK1B | 0.63529925 |
| 105 | MYLK | 0.63379390 |
| 106 | PRKCE | 0.62810440 |
| 107 | CAMK2G | 0.62611829 |
| 108 | PRPF4B | 0.62161329 |
| 109 | CSNK1G3 | 0.61923872 |
| 110 | MAP3K8 | 0.61063660 |
| 111 | ADRBK1 | 0.60822354 |
| 112 | MAPK11 | 0.60498179 |
| 113 | HCK | 0.59319635 |
| 114 | PLK2 | 0.58411819 |
| 115 | PRKCG | 0.57634547 |
| 116 | CDK4 | 0.57428052 |
| 117 | VRK1 | 0.57250041 |
| 118 | ERBB3 | 0.57249566 |
| 119 | TIE1 | 0.55982767 |
| 120 | CDK9 | 0.55390593 |
| 121 | CHEK1 | 0.55382859 |
| 122 | BRSK2 | 0.54518180 |
| 123 | STK11 | 0.53730461 |
| 124 | SMG1 | 0.52167924 |
| 125 | DYRK1A | 0.51336493 |
| 126 | NEK1 | 0.50422162 |
| 127 | BCKDK | 0.49735151 |
| 128 | AKT2 | 0.49439635 |
| 129 | FGR | 0.49289659 |
| 130 | LYN | 0.48922500 |
| 131 | TESK1 | 0.48561212 |
| 132 | AURKB | 0.48541912 |
| 133 | JAK3 | 0.48318862 |
| 134 | NEK9 | 0.47025930 |
| 135 | CSF1R | 0.46883223 |
| 136 | MAPKAPK5 | 0.46479430 |
| 137 | GRK1 | 0.45938091 |
| 138 | ATM | 0.45628719 |
| 139 | PLK3 | 0.44540094 |
| 140 | TYK2 | 0.44191720 |
| 141 | PDK1 | 0.43670385 |
| 142 | CHUK | 0.42850756 |
| 143 | MKNK1 | 0.42792135 |
| 144 | CHEK2 | 0.41842373 |
| 145 | CDK2 | 0.41745357 |
| 146 | PKN2 | 0.41540383 |
| 147 | SGK1 | 0.41066034 |
| 148 | CAMK1 | 0.40188376 |
| 149 | PRKAA2 | 0.39695016 |
| 150 | CSNK1G1 | 0.39618528 |
| 151 | BTK | 0.39569458 |
| 152 | SIK1 | 0.39360789 |
| 153 | FER | 0.38879439 |
| 154 | TLK1 | 0.38594720 |
| 155 | PDK2 | 0.38405447 |
| 156 | IKBKB | 0.38199970 |
| 157 | MAP3K10 | 0.38157568 |
| 158 | CAMK1G | 0.37532188 |
| 159 | PRKG1 | 0.36457068 |
| 160 | MAPKAPK2 | 0.36360063 |
| 161 | DAPK3 | 0.36179817 |
| 162 | TAOK3 | 0.34607588 |
| 163 | ERN1 | 0.33746389 |
| 164 | BRAF | 0.33646975 |
| 165 | MAP3K14 | 0.33616406 |
| 166 | PRKACA | 0.33601156 |
| 167 | TRIB3 | 0.32767281 |
| 168 | UHMK1 | 0.31665412 |
| 169 | DYRK3 | 0.31613798 |
| 170 | WNK3 | 0.30952417 |
| 171 | STK38 | 0.30885758 |
| 172 | CAMK1D | 0.29423466 |
| 173 | MAPK12 | 0.28935513 |
| 174 | PAK3 | 0.28512785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.42398937 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.38972468 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.14467957 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.06602533 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.80126729 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.75749509 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.64173567 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.61693347 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.49165022 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.37320979 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.31656234 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.22751876 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19762425 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19584260 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18573876 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.14206477 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 2.12677385 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.08920479 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 2.08806606 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 2.06738294 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05002017 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 2.00740160 |
| 23 | Cell cycle_Homo sapiens_hsa04110 | 1.92015694 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87670217 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.85264126 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.78290166 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71793873 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.66254701 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66019546 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64938202 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.64580391 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.63490766 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61312501 |
| 34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60285113 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.59733782 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59347794 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52428605 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49825348 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47425167 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46538762 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.43263350 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43111277 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42596000 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.40009080 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37451017 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34944459 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.32935869 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32867403 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32812419 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.32054718 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31238252 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30771382 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29517738 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.26859512 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25239973 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24963439 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23675101 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22325327 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21079191 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19661615 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18835838 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 1.15748828 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.14777520 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14557989 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.13506172 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08833493 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 1.08666084 |
| 68 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.07232943 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06744579 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05952473 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05508879 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04692583 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04188963 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03858744 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03053035 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02936556 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00287211 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99190432 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99187006 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.98070366 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.97541132 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96345385 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95969231 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.94567175 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92893381 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91963236 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.89529417 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89054247 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88588029 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.88055849 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.87640483 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86447958 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85804551 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85394848 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84470307 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84012686 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83921418 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82279814 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81943001 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80935346 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80848526 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.80804834 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80398426 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.78225225 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77684650 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.77152505 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76599777 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76293828 |
| 109 | Purine metabolism_Homo sapiens_hsa00230 | 0.75862796 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.75359811 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74515355 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73915877 |
| 113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73377311 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72209462 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72162425 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70923639 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.70729676 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70061583 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67608250 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64962583 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64421599 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64231221 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63813366 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63513558 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62054719 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61566833 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61111783 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.60349640 |
| 129 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59692431 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58285887 |
| 131 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57666412 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57546077 |
| 133 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56158473 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56034076 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.56016609 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.55486119 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55456998 |
| 138 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55272652 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54430000 |
| 140 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54426308 |
| 141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54289285 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53772843 |
| 143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53174431 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50989844 |
| 145 | Asthma_Homo sapiens_hsa05310 | 0.50173580 |
| 146 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49934166 |
| 147 | Lysine degradation_Homo sapiens_hsa00310 | 0.49885156 |
| 148 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49274541 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48834642 |
| 150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48759924 |
| 151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48158844 |
| 152 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47516424 |
| 153 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47328229 |
| 154 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47000668 |
| 155 | Legionellosis_Homo sapiens_hsa05134 | 0.46356410 |
| 156 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46097567 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46037541 |
| 158 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45751128 |
| 159 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45413743 |
| 160 | Salmonella infection_Homo sapiens_hsa05132 | 0.44817821 |
| 161 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44393613 |
| 162 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43788249 |
| 163 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43762531 |
| 164 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43031552 |
| 165 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42982970 |
| 166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42591570 |
| 167 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42483064 |
| 168 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42396836 |
| 169 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41785219 |
| 170 | Ribosome_Homo sapiens_hsa03010 | 0.41331173 |
| 171 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40475215 |
| 172 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40452777 |
| 173 | Prion diseases_Homo sapiens_hsa05020 | 0.40194318 |
| 174 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39358037 |
| 175 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39113246 |
| 176 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37527934 |
| 177 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37256387 |
| 178 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36119985 |
| 179 | Alcoholism_Homo sapiens_hsa05034 | 0.35860135 |
| 180 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34135437 |
| 181 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33554694 |
| 182 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33345545 |
| 183 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31822900 |
| 184 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31552457 |
| 185 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30892696 |

